Navigation Links
Inheriting a tendency to brain infection

hospital in Paris and genetic epidemiologist Laurent Abel of the Necker Medical School, revealed that a significant proportion of patients with herpes simplex encephalitis had parents who were blood relatives --often first or second cousins--and were therefore at higher than normal risk of inheriting two copies of a faulty gene.

In 2005, Casanova later identified a 15-year-old boy who developed brain damage due to herpes simplex infection. Casanova found that the boy's blood cells failed to produce an important immune signalling molecule, type I interferon, when challenged with the virus in a laboratory flask.

At about the same time, Bruce Beutler of the Scripps Research Institute in La Jolla, California created a mutant mouse that did not respond to certain molecules that normally trigger cells to produce type I interferon. The mouse turned out to be vulnerable to a range of infections, but its susceptibility to herpes simplex had not been tested. "Nevertheless," said Casanova, "the immunological abnormality perfectly matched that found in our patient."

Beutler's mouse carried a mutation in a gene called unc93b. The French team sequenced the human counterpart, unc93b1, and found that their patient carried two mutated copies of this gene. In early 2006, they found a second, unrelated patient who had also inherited two mutated copies of the gene--although the mutation in her case was different. She had survived two episodes of the disease, which had left her partially paralysed and mildly mentally retarded.

The link between interferon production and the disease suggests a new strategy for treatment, Casanova said. "It's like giving insulin to a diabetic patient," he said. "You just replace the missing compound."

Soon, children who come into the intensive care unit with herpes simplex encephalitis may be treated with both the standard antiviral, acyclovir, and with type I interferon, to replace the interferon they lack if
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3

Related biology news :

1. A link is found between morphine addiction and the tendency to explore
2. Controversial drug shown to act on brain protein to cut alcohol use
3. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
4. Mouse brain tumors mimic those in human genetic disorder
5. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
6. First atlas of key brain genes could speed research on cancer, neurological diseases
7. NYU study reveals how brains immune system fights viral encephalitis
8. Stem cells from brain transformed to produce insulin at Stanford
9. Birds brains reveal source of songs
10. Loves all in the brain: fMRI study shows strong, lateralized reward, not sex, drive
11. Revolutionary nanotechnology illuminates brain cells at work

Post Your Comments:
(Date:11/4/2009)...ember 4, 2009 Childhood obesity in the United Sta...an one fourth of advertising on daytime and prime ... continuing questions about the role television pl...ssue of the Journal of Nutrition Education and Be...ldren might be a large contributor to the problem....
(Date:11/4/2009)... Oct. 20 Quest Diagnosti... provider of diagnostic testing, information and s...d September 30, 2009, income from continuing opera...hare, from $160 million, or $0.81 per diluted shar...uarter results were reduced by a $0.03 per share c...
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2RMACT Celebrates Seven Years of Growing Families 57136 1RMACT Celebrates Seven Years of Growing Families 57136 2RMACT Celebrates Seven Years of Growing Families 57136 3RMACT Celebrates Seven Years of Growing Families 57136 4Treating bone loss in breast cancer survivors 9926 1Treating bone loss in breast cancer survivors 9926 2Ecosystem researchers to hold science briefing for policymakers 9925 1
...n in yeast, worms, and flies keeps blood sugar und...ust Cell Metabolism. The findings suggest therapeu... of metabolic disorders, such as type 2 diabetes, ...aid. , The team found that mice with an excess of ...proved glucose tolerance and enhanced insulin secr...
...ired infections can persist for days and even week...ttings, including bed linens, computer keyboard co...h presented today at the 105th General Meeting of ...in-resistant Staphylococcus aureus (MRSA) is a maj...ited States. Staphylococcal infections can cause c...
...,s motor nerve cells grow along proper paths durin... inhibiting spinal-cord neurons from regenerating ...al Center have found. In cultured cells, the resea...ce that normally insulates and stabilizes long ner...the ability of nerve cells to grow through myelin ...
Other Biology News:Sea Ice May Be on Increase in the Antarctic 2Researchers find molecule that inhibits regrowth of spinal nerve cells 2Researchers find molecule that inhibits regrowth of spinal nerve cells 3
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Biotech Ltd. (Amex:,SVA), a leading provider of v...h of Anflu(R), a seasonal influenza vaccine, for 2... Sinovac, Anflu(R) is the only split influenza,vac...vac is undertaking the,sales and marketing program...the adult dosage form of Anflu(R)., Utilizing the...
...ber 11 at 11:00 AM ET, WAYNE, Pa., Sept. 10 Enco...multinational clinical research organization,(CRO)...of the world,s,leading pharmaceutical and biotechn...nted Dr. David Ginsberg, Chief Executive Officer o...sition from Dr. Kai Lindevall, who,was named to th...
...ber of US clinics, CHICAGO, IL, Sept. 10 /PRNewsw...st commercially available bionic hand, today revea...8 National Assembly of the American,Orthotic and P...ovember 3,2008, the company,s RACE Team and Partne...rt to the growing number of prosthetics clinics th...
Other Biology Technology:Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 2Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 2Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 4Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 5Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 6Touch Bionics unveils innovative partner and reimbursement programs at AOPA 2Touch Bionics unveils innovative partner and reimbursement programs at AOPA 3
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: